Overview

Photodynamic Therapy With Porfimer Sodium in Treating Patients With Precancerous Lesions, Cancer, or Other Disease of the Aerodigestive Tract

Status:
Completed

Trial end date:
2010-05-01

Target enrollment:

Participant gender:

Summary

RATIONALE: Photodynamic therapy uses a drug that becomes active when it is exposed to a certain kind of light. When the drug is active, precancerous cells and cancer cells are killed. PURPOSE: This phase II trial is studying the side effects and how well photodynamic therapy with porfimer sodium works in treating patients with precancerous lesions, cancer, or other disease of the aerodigestive tract.

Phase:

Phase 2

Details

Lead Sponsor:

University of Miami
University of Miami Sylvester Comprehensive Cancer Center

Treatments:

Dihematoporphyrin Ether
Hematoporphyrin Derivative
Trioxsalen